Patents by Inventor Roslyn Cohen

Roslyn Cohen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Protocol for monitoring direct thrombin inhibition
    Patent number: 8008086
    Abstract: A hemostasis analyzer, such as the Thrombelastograph® (TEG®) hemostasis analyzer is utilized to measure continuously in real time, the hemostasis process from the initial fibrin formation, through platelet-fibrin interaction and lysis to generate blood hemostasis parameters. The measured blood hemostasis parameters permit evaluation of hemostasis therapies including anticoagulation therapies such as direct thrombin inhibition therapies.
    Type: Grant
    Filed: May 24, 2007
    Date of Patent: August 30, 2011
    Assignee: Cora Healthcare, Inc.
    Inventors: Eli Cohen, Roslyn Cohen
  • Protocol and apparatus for determining heparin-induced thrombocytopenia
    Patent number: 7811792
    Abstract: A hemostasis analyzer, such as the Thrombelastograph® (TEG®) hemostasis analyzer is utilized to measure continuously in real time, the hemostasis process from the initial fibrin formation, through platelet-fibrin interaction and lysis to generate blood hemostasis parameters. The measured blood hemostasis parameters permit determination of heparin-induced thrombocytopenia II complex (HiT II).
    Type: Grant
    Filed: April 27, 2009
    Date of Patent: October 12, 2010
    Assignee: Cora Healthcare, Inc.
    Inventors: Eli Cohen, Roslyn Cohen
  • Method of evaluating patient hemostasis
    Patent number: 7732213
    Abstract: A hemostasis analyzer, such as the Thrombelastograph® (TEG®) hemostasis analyzer is utilized to measure continuously in real time, the hemostasis process from the initial fibrin formation, through platelet-fibrin interaction and lysis to generate blood hemostasis parameters. The measured blood hemostasis parameters permit evaluation of a patient hemostasis condition.
    Type: Grant
    Filed: December 7, 2006
    Date of Patent: June 8, 2010
    Assignee: CoraMed Healthcare, Inc.
    Inventors: Eli Cohen, Roslyn Cohen
  • Protocol and Apparatus for Determining Heparin-induced Thrombocytopenia
    Publication number: 20090208988
    Abstract: A hemostasis analyzer, such as the Thrombelastograph® (TEG®) hemostasis analyzer is utilized to measure continuously in real time, the hemostasis process from the initial fibrin formation, through platelet-fibrin interaction and lysis to generate blood hemostasis parameters. The measured blood hemostasis parameters permit determination of heparin-induced thrombocytopenia II complex (HiT II).
    Type: Application
    Filed: April 27, 2009
    Publication date: August 20, 2009
    Applicant: Cora Healtcare, Inc.
    Inventors: Eli Cohen, Roslyn Cohen, Roger C. Carroll
  • Protocol and apparatus for determining heparin-induced thrombocytopenia
    Patent number: 7524670
    Abstract: A hemostasis analyzer, such as the Thrombelastograph® (TEG®) hemostasis analyzer is utilized to measure continuously in real time, the hemostasis process from the initial fibrin formation, through platelet-fibrin interaction and lysis to generate blood hemostasis parameters. The measured blood hemostasis parameters permit determination of heparin-induced thrombocytopenia II complex (HiT II).
    Type: Grant
    Filed: August 5, 2003
    Date of Patent: April 28, 2009
    Assignee: Haemoscope Corporation
    Inventors: Eli Cohen, Roslyn Cohen, Roger C. Carroll
  • Protocol for Monitoring Direct Thrombin Inhibition
    Publication number: 20080038828
    Abstract: A hemostasis analyzer, such as the Thrombelastograph® (TEG®) hemostasis analyzer is utilized to measure continuously in real time, the hemostasis process from the initial fibrin formation, through platelet-fibrin interaction and lysis to generate blood hemostasis parameters. The measured blood hemostasis parameters permit evaluation of hemostasis therapies including anticoagulation therapies such as direct thrombin inhibition therapies.
    Type: Application
    Filed: May 24, 2007
    Publication date: February 14, 2008
    Inventors: Eli Cohen, Roslyn Cohen
  • Method of Evaluating Patient Hemostasis
    Publication number: 20070184508
    Abstract: A hemostasis analyzer, such as the Thrombelastograph® (TEG®) hemostasis analyzer is utilized to measure continuously in real time, the hemostasis process from the initial fibrin formation, through platelet-fibrin interaction and lysis to generate blood hemostasis parameters. The measured blood hemostasis parameters permit evaluation of a patient hemostasis condition.
    Type: Application
    Filed: December 7, 2006
    Publication date: August 9, 2007
    Applicant: HAEMOSCOPE CORPORATION
    Inventors: Eli Cohen, Roslyn Cohen
  • Protocol for monitoring platelet inhibition
    Patent number: 7179652
    Abstract: A hemostasis analyzer, such as the Thrombelastograph® (TEG®) hemostasis analyzer is utilized to measure continuously in real time, the hemostasis process from the initial fibrin formation, through platelet-fibrin interaction and lysis to generate blood hemostasis parameters. The measured blood hemostasis parameters permit evaluation of platelet inhibition therapy.
    Type: Grant
    Filed: March 7, 2003
    Date of Patent: February 20, 2007
    Assignee: Haemoscope Corporation
    Inventors: Eli Cohen, Roslyn Cohen, Roger Carroll
  • Protocol and apparatus for determining heparin-induced thrombocytopenia
    Publication number: 20050032142
    Abstract: A hemostasis analyzer, such as the Thrombelastograph® (TEG®) hemostasis analyzer is utilized to measure continuously in real time, the hemostasis process from the initial fibrin formation, through platelet-fibrin interaction and lysis to generate blood hemostasis parameters. The measured blood hemostasis parameters permit determination of heparin-induced thrombocytopenia II complex (HiT II).
    Type: Application
    Filed: August 5, 2003
    Publication date: February 10, 2005
    Inventors: Eli Cohen, Roslyn Cohen, Roger Carroll
  • Protocol for monitoring platelet inhibition
    Publication number: 20030219904
    Abstract: A hemostasis analyzer, such as the Thrombelastograph® (TEG®) hemostasis analyzer is utilized to measure continuously in real time, the hemostasis process from the initial fibrin formation, through platelet-fibrin interaction and lysis to generate blood hemostasis parameters. The measured blood hemostasis parameters permit evaluation of platelet inhibition therapy.
    Type: Application
    Filed: March 7, 2003
    Publication date: November 27, 2003
    Inventors: Eli Cohen, Roslyn Cohen, Roger Carroll